专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

SE9603913D0 未知
公开(公告)号：SE9603913D0
公开(公告)日：1996-10-25
申请号：SE9603913
申请日：1996-10-25
申请人： ERNST GUNNAR GARIBALDI LINDEBE , MATS LARHED , ANDERS HALLBERG
发明人： LINDEBERG ERNST GUNNAR GARIBAL , LARHED MATS , HALLBERG ANDERS
IPC分类号： B01J19/12 , C07B37/00 , C07B37/04 , C07B61/00 , C07C1/32 , C07C2/86 , C07C17/266 , C07C45/51 , C07C45/68 , C07C67/343 , C07C209/68 , C07C213/08 , C07C231/12 , C07C253/30 , C07D209/18 , C07D307/28 , C07D333/08 , C07B
摘要： PCT No. PCT/SE97/00794 Sec. 371 Date Nov. 24, 1998 Sec. 102(e) Date Nov. 24, 1998 PCT Filed May 14, 1997 PCT Pub. No. WO97/43230 PCT Pub. Date Nov. 20, 1997Organic reactions catalyzed by palladium, except Pd/C, are conducted with heating by microwave energy. The preferred inorganic reactions involved are coupling reactions in which a new carbon-carbon bond is formed. Preferred reactions are the Heck, Stille and Suzuki reaction. The method provides high yields in very short reaction times.

2. 发明专利

SE9601856D0 未知
公开(公告)号：SE9601856D0
公开(公告)日：1996-05-14
申请号：SE9601856
申请日：1996-05-14
申请人： ERNST GUNNAR GARIBALDI LINDEBE , MATS LARHED , ANDERS HALLBERG
发明人： LINDEBERG ERNST GUNNAR GARIBAL , LARHED MATS , HALLBERG ANDERS
IPC分类号： C07B20060101 , C07B

3. 发明申请

US20090042931A1 Tricyclic Angiotensin II Agonists 有权
标题翻译：三环血管紧张素II激动剂
公开(公告)号：US20090042931A1
公开(公告)日：2009-02-12
申请号：US11918240
申请日：2006-04-12
申请人： Mathias Alterman , Anders Hallberg , Xiongyu Wu
发明人： Mathias Alterman , Anders Hallberg , Xiongyu Wu
IPC分类号： A61K31/4178 , A61P1/00 , A61P9/00 , C07D409/10 , A61K31/4155 , A61K31/437 , C07D471/04 , A61K31/4184 , A61P11/00 , A61P25/00
CPC分类号： C07D409/10
摘要： There is provided compounds of formula I, wherein A, X1, X2, X3, X4, Y1, Y2, Y3, Y4, Z1, Z2, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful as selective agonists of the AT2 receptor, and thus, in particular, in the treatment of inter alia gastrointestinal conditions, such as dyspepsia, IBS and MOF, and cardiovascular disorders.
摘要翻译：提供式I化合物，其中A，X 1，X 2，X 3，X 4，Y 1，Y 2，Y 3，Y 4，Z 1，Z 2，R 4和R 5具有说明书中给出的含义及其药学上可接受的盐，作为AT2受体的选择性激动剂是有用的，因此特别是用于治疗尤其是消化不良，IBS和MOF以及心血管疾病的胃肠道疾病。

4. 发明申请

US20060183780A1 Pyrazole compounds useful in the treatment of inflammation 审中-公开
标题翻译：吡唑类化合物可用于治疗炎症
公开(公告)号：US20060183780A1
公开(公告)日：2006-08-17
申请号：US10547996
申请日：2004-03-12
申请人： Anders Hallberg , Wesley Schaal , Mats Larhed , Kristofer Olofsson , Benjamin Pelcman , Andrei Sanin
发明人： Anders Hallberg , Wesley Schaal , Mats Larhed , Kristofer Olofsson , Benjamin Pelcman , Andrei Sanin
IPC分类号： A61K31/4439 , A61K31/427 , A61K31/4152 , C07D417/02 , C07D403/02
CPC分类号： C07D231/14 , C07D231/18 , C07D231/40 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14
摘要： There is provided a compound of formula (I), wherein R1, R2, R3, X and Y have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a lipoxygenase (e.g. 15-lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.
摘要翻译：提供式（I）的化合物，其中R 1，R 2，R 3，X和Y具有在描述及其药学上可接受的盐，该化合物可用于治疗期望和/或需要抑制脂氧合酶（例如，15-脂肪氧合酶）的活性，特别是治疗炎症的疾病。

5. 发明申请

US20060111376A1 2,4-Diamino quinazoline and pyridopyrimidine ester derivatives as dihydrofolate reductase inhibitors 审中-公开
标题翻译： 2,4-二氨基喹唑啉和吡啶并嘧啶酯衍生物作为二氢叶酸还原酶抑制剂
公开(公告)号：US20060111376A1
公开(公告)日：2006-05-25
申请号：US10525906
申请日：2003-08-27
申请人： Anders Hallberg , Malin Graffner-Nordberg , Arne Boman , Elisabeth Seifert
发明人： Anders Hallberg , Malin Graffner-Nordberg , Arne Boman , Elisabeth Seifert
IPC分类号： A61K31/517 , C07D239/95
CPC分类号： C07D239/95
摘要： The invention provides novel compounds or the formula II: wherein R1, R2, R3 and R4 are independently hydrogen of a group that liberates the free amine in vivo, for example —CO-alkyl, preferably —CO—C1-C3 alkyl or pivalate; or —COhaloalkyl, preferably —CO—C1-C3 haloalkyl, most preferably —CO—C1-C3 chloroalkyl; wherein W is: and @ denotes the points of attachment and wherein the ester can be located in either direction; wherein n and m are independently 0-5; wherein one but not both or X and Y can be nitrogen, or X is C-A and/or Y is C—B; wherein A and B are independently selected from hydrogen, alkyl optionally substituted with a halogen, an electron donor group such as amino, alkylamino, dialkylamino or hydroxy, or an electron acceptor group such as nitro, cyano. trihaloalkyl or amido, alkoxy or halogen; and pharmacologically acceptable salts thereof. Provided that when R1 to R4 are hydrogen, both X and Y are C—H, n is 1 and —(CH2)n— is attached to the bridging oxygen of the ester group W, then m cannot be 0 or 1.
摘要翻译：本发明提供了新的化合物或式II：其中R 1，R 2，R 3和R 4，独立地是在体内释放游离胺的基团的氢，例如-CO-烷基，优选-CO-C 1 -C 3烷基或特戊酸酯; 或-CO卤代烷基，优选-CO-C 1 -C 3卤代烷基，最优选-CO-C 1 -C 3 - / SUB-氯烷基; 其中W是：和@表示连接点，并且其中酯可以位于任一方向上; 其中n和m独立地为0-5; 其中一个但不是两个或X和Y可以是氮，或X是C-A和/或Y是C-B; 其中A和B独立地选自氢，任选被卤素取代的烷基，电子给体基团如氨基，烷基氨基，二烷基氨基或羟基，或电子受体基团如硝基，氰基。三卤代烷基或酰氨基，烷氧基或卤素; 及其药理学上可接受的盐。假设当R 1至R 4为氢时，X和Y都是CH，n是1和 - （CH 2 CH 2）_{n 连接到酯基W的桥连氧上，则m不能为0或1。}

6. 发明授权

US06551467B1 Microwave facilitated allyllic substitution 失效
标题翻译：微波促进了allyllic取代
公开(公告)号：US06551467B1
公开(公告)日：2003-04-22
申请号：US09786199
申请日：2001-04-16
申请人： Ulf Bremberg , Anders Hallberg , Mats Larhed , Christina Moberg , Nils-Fredrik Kaiser
发明人： Ulf Bremberg , Anders Hallberg , Mats Larhed , Christina Moberg , Nils-Fredrik Kaiser
IPC分类号： C07F500
CPC分类号： C07B53/00 , C07B37/04 , C07C67/343 , C07C69/618
摘要： The present invention is draw to microwave heating of a transition metal-catalysed organic reaction, in which a catalyst complex between a transition metal and an auxiliary ligand or ligands, the ligand being asymmetric or symmetric, monodentate or bidentate, results in highly chemoselective, regioselective, and stereoselective allylic substitution reactions. Molybdenum or palladium complexes form suitable catalytic systems with a plethora of ligands in a variety of solvents for such microwave facilitated nucleophilic substitution reactions.
摘要翻译：本发明涉及过渡金属催化的有机反应的微波加热，其中过渡金属和辅助配体或配体之间的催化剂络合物，不对称或对称的单齿或双齿配体导致高度化学选择性的区域选择性，和立体选择性烯丙基取代反应。钼或钯络合物形成合适的催化体系，在各种溶剂中具有多种配体，用于这种微波促进的亲核取代反应。

7. 发明授权

US08067418B2 Tricyclic angiotensin II agonists 有权
标题翻译：三环血管紧张素II激动剂
公开(公告)号：US08067418B2
公开(公告)日：2011-11-29
申请号：US11918238
申请日：2006-04-12
申请人： Mathias Alterman , Anders Hallberg , Xiongyu Wu
发明人： Mathias Alterman , Anders Hallberg , Xiongyu Wu
IPC分类号： A61K31/41 , C07D235/12 , C07D235/14 , C07D239/02 , C07D241/02 , C07D333/02
CPC分类号： C07D409/10
摘要： There is provided compounds of formula I, wherein the dotted line, X1, X2, X3, A, Y1, Y2, Y3, Y4, Z1, Z2, R2 and R3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful as selective agonists of the AT2 receptor, and thus, in particular, in the treatment of inter alia gastrointestinal conditions, such as dyspepsia, IBS and MOF, and cardiovascular disorders.
摘要翻译：提供式I化合物，其中虚线X1，X2，X3，A，Y1，Y2，Y3，Y4，Z1，Z2，R2和R3具有说明书中给出的含义及其药学上可接受的盐，哪些化合物可用作AT2受体的选择性激动剂，因此特别是用于治疗尤其是消化不良，IBS和MOF以及心血管疾病的胃肠道疾病。

8. 发明授权

US07807677B2 HIV protease inhibitors 失效
标题翻译： HIV蛋白酶抑制剂
公开(公告)号：US07807677B2
公开(公告)日：2010-10-05
申请号：US11884224
申请日：2006-02-09
申请人： Jenny Ekegren , Anders Hallberg , Hans Wallberg , Bertil Samuelsson , Mahalingam Kannan
发明人： Jenny Ekegren , Anders Hallberg , Hans Wallberg , Bertil Samuelsson , Mahalingam Kannan
IPC分类号： C07C271/22 , C07C275/24 , C07C311/06 , C07D213/42 , C07D241/12 , A61K31/18 , A61K31/17 , A61K31/325 , A61K31/38
CPC分类号： C07D213/42 , C07C271/22 , C07C275/24 , C07C311/06 , C07C2602/08 , C07D241/12 , C07D261/08 , C07D263/52 , C07D303/48 , C07D307/33 , C07D317/58 , C07D333/58
摘要： Compounds of the formula I: wherein R1, R2, X and N are as defined in the specification; E is N, CH; A′ and A″ are terminal groups as defined in the specification. The compounds have utility as HIV-1 protease inhibitors.
摘要翻译：式I化合物：其中R1，R2，X和N如说明书中所定义; E为N，CH; A'和A“是说明书中定义的末端基团。该化合物可用作HIV-1蛋白酶抑制剂。

9. 发明授权

US09271304B2 Method for increasing the address space for mobile terminals in a wireless network 有权
标题翻译：一种用于增加无线网络中的移动终端的地址空间的方法
公开(公告)号：US09271304B2
公开(公告)日：2016-02-23
申请号：US14363148
申请日：2011-12-09
申请人： Anders Holm , Håkan Axelsson , Anders Hallberg , Oskar Myrberg , Jonas Nilsson
发明人： Anders Holm , Håkan Axelsson , Anders Hallberg , Oskar Myrberg , Jonas Nilsson
IPC分类号： H04W4/00 , H04W72/12 , H04W76/02 , H04L5/00
CPC分类号： H04W72/1278 , H04L5/003 , H04W76/11
摘要： A method, in a base station subsystem (10), of allocating radio resources to mobile stations (20) in a wireless communication system (1) involves the base station subsystem (10) assigning a respective Temporary Block Flow (TBF) to each mobile station (20) in a cell (40) in the communication system (1), and then assigning to each TBF a Temporary Flow Identity (TFI), at least one Packet Data Channel (PDCH), and an Uplink State Flag (USF) if the TBF is an uplink TBF. The base station subsystem (10) then selects different training sequences from a plurality of available training sequences and assigns a respective different selected training sequence to two or more TBFs wherein these two or more TBFs share the same assigned Temporary Flow Identity (TFI), the same assigned Packet Data Channel (PDCH), and/or the same assigned Uplink State Flag (USF) if the TBF is an uplink TBF.
摘要翻译：一种在基站子系统（10）中向无线通信系统（1）中的移动台（20）分配无线电资源的方法，其特征在于，所述基站子系统（10）将相应的临时块流（TBF）分配给每个移动台在通信系统（1）中的小区（40）中的站（20），然后向每个TBF分配临时流标识（TFI），至少一个分组数据信道（PDCH）和上行链路状态标志（USF）如果TBF是上行链路TBF。然后，基站子系统（10）从多个可用的训练序列中选择不同的训练序列，并将相应不同的选择的训练序列分配给两个或更多个TBF，其中这两个或更多TBF共享相同的分配临时流标识（TFI），相同的分配数据信道（PDCH），和/或相同的分配的上行链路状态标志（USF），如果TBF是上行链路TBF。

10. 发明申请

US20090069382A1 Bicyclic Angiotensin II Agonists 有权
标题翻译：双相血管紧张素II激动剂
公开(公告)号：US20090069382A1
公开(公告)日：2009-03-12
申请号：US11918241
申请日：2006-04-12
申请人： Mathias Alterman , Anders Hallberg , Murugaiah Andappan Murugaiah Subbaiah
发明人： Mathias Alterman , Anders Hallberg , Murugaiah Andappan Murugaiah Subbaiah
IPC分类号： A61K31/381 , C07D409/00 , C07D333/34 , A61P9/00 , A61P25/00 , A61P11/00 , A61P1/00 , A61K31/4436
CPC分类号： C07D409/12 , C07D333/34 , C07D333/40
摘要： There is provided a compound of formula I, wherein R1a, R1b, X, Y1, Y2, Y3, Y4, Z1, Z2, R2 and R3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful as selective agonists of the AT2 receptor, and thus, in particular, in the treatment of inter alia gastrointestinal conditions, such as dyspepsia, IBS and MOF, and cardiovascular disorders.
摘要翻译：提供了式I化合物，其中R 1a，R 1b，X，Y 1，Y 2，Y 3，Y 4，Z 1，Z 2，R 2和R 3具有本说明书中给出的含义及其药学上可接受的盐， AT2受体的选择性激动剂，特别是治疗胃肠道疾病如消化不良，IBS和MOF以及心血管疾病。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式